Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-15-009534)

Filing Details

Accession Number:: 0001213900-15-009534
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-12-17 09:36:39
Reporting Period:: 2015-12-15

Filing Date:: 2015-12-17
Accepted Time:: 2015-12-17 09:36:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1553643	Relmada Therapeutics Inc.	RLMD	Pharmaceutical Preparations (2834)	455401931

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1565832	Sergio Traversa	C/O Relmada Therapeutics, Inc. 757 Third Avenue, Suite 2018 New York NY 10017	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-12-15	241	$2.92	320,593	No	4	P	Direct
Common Stock	Acquisiton	2015-12-15	2,759	$2.99	323,352	No	4	P	Direct
Common Stock	Acquisiton	2015-12-15	2,370	$2.98	325,722	No	4	P	Direct
Common Stock	Acquisiton	2015-12-15	5,600	$2.91	331,322	No	4	P	Direct
Common Stock	Acquisiton	2015-12-15	4,358	$3.00	335,680	No	4	P	Direct
Common Stock	Acquisiton	2015-12-15	1,600	$3.40	337,280	No	4	P	Direct
Common Stock	Acquisiton	2015-12-15	42	$3.39	337,322	No	4	P	Direct
Common Stock	Acquisiton	2015-12-15	200	$3.34	337,522	No	4	P	Direct
Common Stock	Acquisiton	2015-12-15	1,800	$3.42	339,322	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct